Jinhe Biotechnology Co Ltd (002688) — Financial Flexibility Index
Jinhe Biotechnology Co Ltd (002688) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of CN¥313.19 Million (operating CF CN¥229.93 Million minus capex CN¥83.27 Million) represents 0% of total liabilities (CN¥2.99 Billion). Check strategic asset allocation of Jinhe Biotechnology Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jinhe Biotechnology Co Ltd Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Jinhe Biotechnology Co Ltd across 17 annual periods. See 002688 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jinhe Biotechnology Co Ltd (2008–2024)
Year-by-year free cash flow to debt coverage for Jinhe Biotechnology Co Ltd. For the full company profile including market capitalisation, see 002688 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥860.66 Million | CN¥498.42 Million | CN¥3.15 Billion | ▲ +22.3% |
| 2023 | 0.22x | CN¥655.98 Million | CN¥198.77 Million | CN¥2.94 Billion | ▼ -11.8% |
| 2022 | 0.25x | CN¥526.63 Million | CN¥124.47 Million | CN¥2.08 Billion | ▼ -35.5% |
| 2021 | 0.39x | CN¥536.70 Million | CN¥152.98 Million | CN¥1.37 Billion | ▲ +38.1% |
| 2020 | 0.28x | CN¥462.09 Million | CN¥258.08 Million | CN¥1.63 Billion | ▼ -5.3% |
| 2019 | 0.30x | CN¥461.03 Million | CN¥282.19 Million | CN¥1.54 Billion | ▲ +62.4% |
| 2018 | 0.18x | CN¥287.35 Million | CN¥117.17 Million | CN¥1.56 Billion | ▲ +9.1% |
| 2017 | 0.17x | CN¥223.82 Million | CN¥27.25 Million | CN¥1.32 Billion | ▼ -56.7% |
| 2016 | 0.39x | CN¥420.98 Million | CN¥292.41 Million | CN¥1.08 Billion | ▼ -9.2% |
| 2015 | 0.43x | CN¥357.05 Million | CN¥214.97 Million | CN¥830.68 Million | ▼ -16.8% |
| 2014 | 0.52x | CN¥290.51 Million | CN¥-58.02 Million | CN¥562.50 Million | ▼ -80.5% |
| 2013 | 2.64x | CN¥308.87 Million | CN¥148.32 Million | CN¥116.81 Million | ▲ +199.9% |
| 2012 | 0.88x | CN¥123.31 Million | CN¥88.81 Million | CN¥139.83 Million | ▲ +103.2% |
| 2011 | 0.43x | CN¥146.02 Million | CN¥106.59 Million | CN¥336.44 Million | ▼ -7.3% |
| 2010 | 0.47x | CN¥172.84 Million | CN¥118.05 Million | CN¥369.09 Million | ▲ +328.3% |
| 2009 | 0.11x | CN¥46.20 Million | CN¥23.20 Million | CN¥422.56 Million | ▲ +8.6% |
| 2008 | 0.10x | CN¥39.14 Million | CN¥11.64 Million | CN¥388.63 Million | — |